Meta-Analysis Links ADHD to Elevated Death Risk, While Treatment May Lower It
A review of 16 million people found that ADHD was associated with a 71% higher risk of death from any cause. Risks were also elevated for suicide, injury, and natural causes. ADHD medication use was tied to lower all-cause mortality, though that finding came from only three studies.
The review pooled 19 studies covering nearly 16 million people, most of them male. It included research published through July 2025 and defined ADHD in several ways, including clinical diagnosis, self-report, trait measures, and genetic risk scores.
Beyond overall mortality, the analysis found higher risks for suicide, injury, and natural causes. Possible pathways include impulsivity, emotional dysregulation, risk-taking, depression, smoking, alcohol use, healthcare barriers, and higher rates of cardiovascular or metabolic conditions. Medication was linked to lower mortality, but only three studies supported that result.
This finding could shape how clinicians, patients, and families view ADHD as a condition with long-term health implications, not just academic or behavioral challenges. It may encourage earlier assessment and treatment discussions, especially for adults and older groups. Greater awareness could also influence workplace support, mental health services, and preventive care, though the treatment finding rests on only three studies.